References - Finance

Here‘s the season to be jolly …. But make sure you still pay your taxes! Read Mr Scroog

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

e as the Inland Revenue, Hacienda or any other tax authority you care to name!

It’s no

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

t all bad news though when it comes to keeping as much of your hard-earned money away f

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

om Scrooge’s coffers. Despite the various and continuing attempts to close doors that a

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

llow for him to be beaten, there remain options open to beat him!

For example, a lot o

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

f folk here are retired and rely heavily on pension and investment income. They probabl

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

get taxed on both subject to levels of income and, for their investments, where and ho

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

w their capital is placed. Despite the EU Directive implemented in the summer of 2005 t

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

o apply a ‘withholding’ on certain incomes and also to allow reporting to revenue autho

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ities, there remain windows that can be exploited legitimately to avoid both. That can

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

make a big difference to ordinary folk; a saving of 30% of your income is not to be ign

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ored.

And then there is question as to whether borrowing to buy here, or even to relea

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

e equity, is viable. When you consider the potential economic benefits of doing so, esp

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ecially via ‘Interest Only’ mortgages, it is surprising to me that anyone would want to

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

repay a mortgage using capital and interest, if ever! The effects of cheap financing,

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ositive investment returns long term, mitigating Inheritance Tax and so on, make the de

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

cision pretty clear cut in my eyes. But then I am bound to say that I hear you say! But

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

numbers seldom lie if you take the time to scrutinise them fully …and the tax man has

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

habit of doing that! So why not take a leaf out of his book and see if you can beat hi

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

m at his own game?

Merry Christmas to all of our readers …and especially to Mr Scrooge

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.references.org.ua/article/116089/references-Merry-Christmas-Mr-Scrooge.html">Merry Christmas Mr. Scrooge!</a>

BB link (for phorums):
[url=http://www.references.org.ua/article/116089/references-Merry-Christmas-Mr-Scrooge.html]Merry Christmas Mr. Scrooge![/url]

Using a variety of female celebrities, infomercial producers have once again created a huge market where none existed. That’s not to say that make up products didn’t exist. They did. And they were a multibillion dollar industry long before anybody ever thought of infomercials.

Outsourcing: a complex series of tradeoffs Outsourcing originated and became popular as a cost-saving strategy during a recessionary environment. In today’s economy and labor market, organizations looking for differentiated growth solutions should avoid outsourcing when based solely on cost savings. Organizations have now begun to recognize the real costs and inherent risks of outsourcing. Instead of simplifying operations, outsourcing often introduces complexity, increased cost, and friction into the value chain, requiring more senior management attention and deeper management skills than anticipated. Companies Are Concerned About Intellectual Property and Confidentiality Risks, Loss of Institutional Knowledge, and Loss of Control Over Outsourced Functions. In this situation it becomes very important to analyse the whole scenario once again in the light of the fact that weather “outsourcing” is fulfilling its purpose of cost saving , enhanced efficiency etc, or it is backfiring. Keeping in view the advantages of outsourcing this paper tries to highlight the complex series of various tradeoffs like cost savings versus growth, speed versus quality of service delivery, and maintaining organizational cohesion versus knowledge and innovation. This paper tries to find out the profitability of the tradeoffs & suggest the viability of outsourcing in various fields.

The Purpose of Audio Books Audio books have stood the test of time for only one simple reason: they clearly fill a demand. Some people prefer them, depending on what activity they’re engaged in. Others choose them as a way to engage the imagination with a little help of well-acted audio material. Still others need them. To those people, audio books are indispensable tools that put feeling and depth to what otherwise would be bumps on a page as brail.

Tags

Links

References - Merry Christmas Mr. Scrooge!

Related Articles: